Chemotherapy for advanced aggressive lymphoma: more is better ...isn't it?
National Cancer Institute, Frederick Cancer Research Facility, MD.
D L
DL
Longo
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D006801:Humans; D008223:Lymphoma / Q000188:drug therapy*